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ABSTRACT 
Autism spectrum disorder (ASD) is an umbrella-term for neurodevelopmental conditions 
characterized by both impairments in communication and social interaction and unusually 
restricted and repetitive or stereotyped interests and behaviors. Although proven to have a 
strong genetic etiology, the full biological background of ASD remains unclear. The higher 
frequency of ASD among males implies that a sex-related perspective may shed light on both 
the etiology and behavioral differences between males and females with ASD.  
The main aim of this thesis was to explore male and female ASD phenotypes and their 
possible relation to sex hormones, beyond the well-established high systemizing—low 
empathizing personality observed by the extreme male brain theory of autism. 
Studies I and II examined sex-dimorphic parameters such as sex hormone levels, 
anthropometry, self-rated gender identity, gender role and sexuality in 26 men and 24 women 
with high-functioning ASD and 53 age- and gender-matched neurotypical controls. 
Photographs of faces and bodies as well as voice recordings were blindly assessed with 
respect to gender coherence. Women with ASD had higher testosterone levels and less 
feminine facial features, while men in the ASD group were assessed as having less masculine 
body characteristics and voice quality than respective controls. A weak gender identity and 
low libido was more common in adults with ASD than in the control group.  
The hypothesis of prenatal testosterone as a risk factor for developing ASD and attention 
deficit/hyperactivity disorder (ADHD) was tested in study III in a cohort of dizygotic twins 
from the Child and Adolescent Twin Study in Sweden (CATSS). Parent-reported autistic and 
ADHD traits were compared between female index twins with either a co-twin brother or a 
co-twin sister. Contrary to what could be expected from a presumed testosterone transfer 
from a co-twin brother to his sister, girls with a co-twin brother had lower ASD and ADHD 
scores as compared to those who had a co-twin sister.  
Study IV examined psychometric properties as well as sex/gender differences in RAADS-14 
Screen, a short version of the RAADS-R self-assessment questionnaire for ASD. Responses 
from 135 adults with ASD, 508 adults with other psychiatric disorders and 590 non-
psychiatric controls were analyzed, showing satisfactory psychometric properties for men and 
women alike. Women scored higher than men in the sensory reactivity domain across all 
groups. 
In conclusion, aberrations in the expression of sex-dimorphic traits are present in ASD. 
Androgyny, weak gender identity and low libido seem overrepresented along with an extreme 
male cognitive style. These patterns are not easily explained solely by an effect of increased 
prenatal androgen blood levels. The observed sex-differences in ASD underscore the 
necessity of acknowledging possible diagnostic and biological sex-differences when 
conducting research on ASD.  
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1 INTRODUCTION 
Autism spectrum disorder (ASD) comprises a continuum of conditions with similar 
behavioral difficulties and aberrations in social interaction and communication as well as 
unusually restrictive and repetitive behavioral patterns observable from early childhood. 
ASD is a heterogeneous disorder with individual variation in both severity of impairment and 
level of intelligence. A distinctive feature in the whole range of ASD is male predominance. 
Most cases are diagnosed at an early age and a minority of children diagnosed with ASD 
present with a regression of previously developed abilities.
1
 ASD commonly co-occurs with 
other neurological disorders such as epilepsy, intellectual disability, schizophrenia or 
Attention Deficit/Hyperactivity Disorder (ADHD) as well as other somatic manifestations, 
for example gastrointestinal problems, sleep disturbances and dysmorphic features.
2
  
Diagnostics and research on ASD have traditionally focused on boys, however, interest in 
the clinical picture for adolescents and adults with ASD has increased in recent decades 
resulting in a rising number of adult diagnoses and an increased interest in comorbidities, 
sex-differences, and outcomes in adults with ASD. Theories associating ASD with extreme 
male intellect and an autistic spectrum fading into the normal population have opened the 
ASD research field for studies of traits and sex differences. 
 
1.1 AUTISTIC TRAITS 
The concept of autism and core autistic traits was first described in the first half of the 
twentieth century. In 1943, Leo Kanner described cases of “early infantile autism”,3 a low 
functioning ASD including mental retardation and little to no language. The typical traits of 
high functioning ASD were described already in 1926 by the Russian psychiatrist Grunya 
Efimovna Sukhareva
4
 and in 1944 by Hans Asperger.
5
 Each of these three pioneers 
thoroughly described the core autistic traits that are included in modern diagnostic criteria for 
ASD. Individuals with ASD show persistent impairments in social interaction and 
communication, including abnormal social-emotional reciprocity, difficulties in initiating and 
maintaining social interactions, deficits in nonverbal communication necessary for social 
engagement (for example, poor eye contact), and atypical speech. Further, individuals with 
ASD also present restricted patterns of behaviors and interests, including motor stereotypies, 
inflexibility to routines and insistence on sameness as well as circumscribed and fixated 
interests. Motor difficulties are also very common in this group.
6–8
  
In 2013, with the new version of the Diagnostic and Statistical Manual of Mental Disorders, 
DSM-5, the previously separately defined disorders ‘autistic disorder’, ‘Asperger disorder’, 
‘childhood disintegrative disorder’ and ‘pervasive developmental disorder not otherwise 
specified’ that described different levels of language development, intelligence and number 
of autistic traits were replaced by the collective term ‘autism spectrum disorder’ (ASD) to 
 2 
acknowledge the difficulties in distinguishing distinct and clinically relevant autistic 
phenotypes based on those characteristics. 
An abnormal response to sensory input is a common trait in ASD, with over 90% of those 
diagnosed with ASD displaying reduced or enhanced sensitivity of some kind.
9–11
 Although 
mentioned in the original case reports, it was left out from the DSM-III and DSM-IV criteria, 
but was included as “hyper- or hypo-reactivity to sensory input or unusual interest in sensory 
aspects of the environment” in the DSM-5 criteria. 
The core symptoms of autism are believed to be an effect of altered neuro-cognitive 
mechanisms. Two generalized cognitive mechanisms have been suggested to explain the core 
ASD symptoms: deficits in empathizing and an augmented tendency to systemize.
12
 Within 
the empathizing concept lies the ability to identify mental states to self and others and to 
predict and understand other people’s behavior accordingly, known as the theory of mind,13,14 
and also to react emotionally appropriately to another person’s thoughts and feelings.15 
Systemizing is the drive to study, construct and maintain systems. The interplay between a 
strong need to systemize and a weak ability to empathize explains impaired and stereotyped 
social behavior and communication as well as narrow interests and resistance to change.
15
  
 
1.2 THE EXTREME MALE BRAIN THEORY OF AUTISM 
The capacities and inclinations to empathize and systemize varies among all individuals and 
have been suggested to be two different and important cognitive dimensions.
15
 Two self-
evaluation tests, the Systemizing Quotient (SQ)
16
 and the Empathy Quotient (EQ)
17
 have 
been developed to measure and describe cognitive style on these dimensions. Large studies of 
EQ and SQ in the general population show gender differences at a group level with more 
males reporting a strong drive to systemize and more females reporting a strong drive to 
empathize.
15,18,19
 This female advantage in empathizing also results in an ability to decipher 
emotions from eye expressions in the Reading the Mind in the Eyes test
20
 and pinpointing 
socially inappropriate behavior in short stories in the Faux Pas test.
21
 Males have typically 
tested better on the Embedded Figures test,
22
 being quicker to recognize a simple shape 
embedded in a complex shape.
23
 Individuals with ASD, with their extreme drive to systemize 
and impairments in the empathy domain, can thus be regarded as having an extreme male 
intellect on these cognitive dimensions, a theory that has been named The extreme male brain 
theory of autism (EMB).
24
 From a neurodevelopmental point-of-view, an extreme male 
intellect indicates that a masculinization of the brain has taken place during fetal brain 
development. The EMB has focused mainly on brain masculinization caused by elevated 
levels of prenatal androgens, especially testosterone, but does not exclude effects of other 
masculinizing factors such as genetic aberrances in the X- and Y-chromosomes.
25
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1.3 ETIOLOGY 
ASD comprises a set of neurodevelopmental conditions with a broad etiological base that 
gives rise to the autistic core symptoms. However, a detailed etiology of ASD has not been 
established. Large studies of twin pairs, high-risk infant siblings and families have 
estimated the heritability of ASD to be around 50%,
26,27
 with a concordance in ASD 
diagnosis of 76-95% between monozygotic twins.
28
 This indicates a strong genetic 
influence with additional gene-environment interactions. 
1.3.1 Genetic factors 
Several known genetic disorders, such as fragile X syndrome, tuberous sclerosis, Smith–
Magenis syndrome, Rett syndrome and Prader–Willi syndrome29–32 often present with ASD. 
The disorder is also common in individuals born pre-term; however, most cases of ASD have 
no such straightforward etiology. Genetic studies have identified many genes associated with 
ASD. However, the identified genes only explain 10-20% of the total ASD population. 
These candidate genes are very diverse but, interestingly, a subset are related to synapse 
function, immune function, and sex hormone regulation
33–35
 – all functions that have been 
related to ASD (e.g. altered synaptic pruning,
36
 maternal infection associated with increased 
ASD risk
37
 and elevated levels of prenatal testosterone associated with an increased number 
of autistic traits in children
38
).   
1.3.2 Environmental factors 
The environmental portion of the ASD etiology appears pre- or perinatal, caused mostly by 
events in first or second trimester that augment the effect of existing genetic aberrations. 
Prenatal environmental factors that have been suggested to increase risk for ASD are vitamin 
D insufficiency,
39
 toxins, immunological factors such as maternal infection and 
autoimmunity,
37
 and deficient testosterone regulation.
40
 
1.3.2.1 Immunological factors 
There are several indications that immunological factors affect the development of ASD 
subtypes. Several ASD candidate genes play important roles in immune function,
34
 and 
maternal infection in the 1-2 trimesters is associated with higher rates of ASD in the child.
41,42
 
Additionally, both bacterial and viral maternal immune activation have yielded offspring with 
autism-like features in mice, rats and primates. Similar autism-like behaviors were also 
achieved by gestational flu exposure in mice.
43
  
1.3.2.2 ASD and prenatal testosterone exposure 
During fetal development, testosterone (T) is a key player in masculinization. In line with the 
EMB theory there is some evidence for an association between elevated levels of prenatal 
androgens, especially testosterone, and ASD. Amniotic testosterone levels have been found to 
positively correlate with poorer social skills at age four according to parent ratings.
44
 One 
study has also indicated that steroidogenic activity is elevated in the amniotic fluid of fetuses 
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who will develop into children who receive ASD diagnoses.
45
 An increased number of 
autistic traits
46
 and reduced empathy
47
 have been found in women with congenital adrenal 
hyperplasia (CAH), a genetic disease that results in high prenatal testosterone levels in both 
sexes. 
The influence of androgens in women with ASD is further supported by the fact that 
androgen-related conditions are more common than expected in these patients
48
 and by the 
observation that autistic traits in early childhood have been associated with late menarche, 
which is related to androgen status.
49
 A recent study found that maternal polycystic ovary 
syndrome (PCOS) increased the odds of having a child with ASD by 59%,
50
 further 
indicating a relation between elevated maternal testosterone levels and ASD. 
 
1.4 IS THERE AN AUTISTIC BRAIN? 
Although there are no biomarkers available that are specific enough to diagnose ASD, studies 
using brain imaging and pathological analyses of brain tissue have been used to identify 
differences in brain development as well as activation and connectivity in individuals with 
ASD. An altered growth trajectory of the whole brain has been suggested for ASD and 
considered a central neurodevelopmental feature of the disorder.
51
 Leo Kanner
3
  reported 
unusually large heads in 5 of 11 cases in his original description of autism and, after that, a 
higher frequency of large head circumference associated with macrocephaly has been 
reported in several studies.
52
 Brain MRI studies have confirmed an increased frequency of 
enlarged cerebrum volume in ASD as compared with typically developed (TD) individuals 
throughout childhood.
51
 However, this brain enlargement is only present in a subgroup of 
ASD and is mostly associated with regressive ASD.
53
 Notably, microcephaly has also been 
reported in ASD children.
54
  
Differences in hippocampal and cerebellar volume have also been indicated in individuals 
with ASD.
55,56
 Furthermore, compared with age matched TD children, variation in amygdala 
volume is greater in 2-4 year-old children with ASD, and on average is bilaterally 
increased.
57,58
 Bilateral activation of the amygdala has been related to the restricted repetitive 
interests in individuals with ASD as well as strong interests in TD people. Several aspects of 
social impairment related to autism, such as processing of facial emotions and joint attention 
ability, have been suggested to be linked to amygdala abnormalities.
58
 
Several studies have also shown alterations in functional connectivity in ASD patient with 
decreased frontal-posterior connectivity and over-connectivity within the extrastriate cortex, 
frontal and temporal regions and amygdala.
59
 Abnormal cortical growth trajectories together 
with alterations in functional connectivity and post-mortem findings of an excess of neurons 
in the prefrontal cortex in children with ASD
60
 suggest an effect of abnormal synaptic 
pruning during ASD development.
61,62
 
  5 
There is also some evidence for aberrant activation of brain regions related to theory of mind 
in individuals with ASD as compared with TD individuals.
63
 Regions affected include the 
insula, posterior and anterior cingulate cortex, caudate nucleus, precuneus, lateral occipital 
cortex, and supramarginal gyrus. 
1.4.1.1 Sex differences in ASD 
Very few structural neuroimaging studies of ASD have focused on females; however there is 
some evidence of sex differences in early brain growth trajectories in ASD.
36,53
 It has also 
been suggested with some evidence that preschool-aged girls with ASD show more neural 
abnormalities in the amygdala, temporal lobe, and cerebellum than boys of the same age with 
ASD.
64,65
 
 
1.5 DIAGNOSING ASD 
The diagnostic procedure for ASD is based on a clinical assessment of core autistic traits in 
conjunction with impairment of overall function in relation to defined diagnostic criteria.  
The clinical assessment procedure for diagnosing ASD is an extensive process typically 
performed by a team that includes a certified psychologist and a fully trained psychiatrist 
specialized in diagnosing ASD. In adults, this multidisciplinary assessment includes 
observations of behaviors, history of childhood symptoms, results from structured and semi-
structured interviews with the patient, assessment of intellectual ability and adaptive 
functioning and, when possible, an interview with a parent. A full assessment takes 
approximately 20 hours to complete. 
Self-assessment questionnaires are often a part of the psychiatric diagnostic process in adults. 
Written questionnaires may relieve some patients from social stress and allow more time for 
introspection before responding. However, self-assessment is a subjective measure colored by 
the respondents’ willingness to be honest counter-balanced by the drive to align with social 
norms, varying lack of self-insight and interpretation of the questions. It has been discussed 
whether the core symptoms of ASD might impair the individual’s ability for personal 
introspection,
14
 implying that self-rating questionnaires could be unsuitable in this group, 
however studies have shown that most adults with ASD and normal intelligence will validly 
self-assess both autistic and other personality traits.
66–68
 The self-assessment questionnaires 
most widely used in the diagnostic procedure for ASD, and also included in the UK National 
Institute for Health and Care Excellence (NICE) guidelines, are the Ritvo Autism and 
Asperger Diagnostic scale – Revised (RAADS-R),67 the Autism Spectrum Quotient (AQ)69 
and the EQ.
17
  
Parental assessment is an important part of ASD diagnostics. Examples of parental interview 
instruments are the semi-structured interview Autism Diagnostic Interview-Revised (ADI-
R),
70
 the Diagnostic Interview for Social and Communication Disorders (DISCO),
71
 the 
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Autism - Tics, AD/HD and other Comorbidities inventory (A-TAC),
72
 a parental telephone 
interview, and parent report questionnaires, the Social Responsiveness Scale (SRS)
73
 and 
AQ-Child.
74
 In adults and adolescents, the parental interview is valuable to give a perspective 
of childhood symptoms. In child diagnostics parents contribute important information about 
behaviors and impairments in daily life that may not be visible during clinical sessions. 
Further, symptom debut and symptom perseverance are important factors where parents may 
also provide important information for adolescent and adult assessments. Difficulties with 
parental interviews include bias due to different expectations depending on the child’s 
sex/gender or comparisons between siblings. 
1.5.1 Diagnostic challenges 
The current classification systems DSM-5 and International Classification of Diseases – 10th 
Ed. (ICD-10), aim to classify clinically meaningful groups of symptoms, that is, common 
clinical appearances, into different diagnoses. As psychiatric disorders currently lack 
biological diagnostic markers, the borders between different psychiatric disorders are not 
clear-cut increasing misdiagnosis risk in patients with an ambiguous phenotype. Specifically, 
it has been suggested that females with ASD present with a slightly different phenotype than 
males. 
1.5.1.1 Differential diagnostics 
The instruments used when diagnosing ASD are very good at recognizing ASD symptoms 
(high sensitivity) and weeding out non-psychiatric patients (high specificity). What 
complicates these diagnostics is that many patients have co-occurring psychiatric disorders 
with symptoms that may cause diagnostic confusion. An adult patient presenting with 
anxiety, difficulties with social interaction, dysphoria and difficulties concentrating may 
suffer from ASD, but the same symptoms are also common in other psychiatric diagnoses 
such as depression, ADHD and schizophrenia. Thus, the main difficulty in diagnosing such a 
patient is not to identify that she is suffering from a psychiatric disorder but to identify which 
particular diagnosis/es fits the best. As in-depth assessment is time consuming for psychiatric 
disorders in general and for neuropsychiatric disorders in particular, only those assessment 
procedures that are deemed necessary are initiated. 
For many other psychiatric diagnoses, short questionnaires are available for quick screening 
to decide whether further evaluation is necessary. For ASD, short questionnaires have been 
lacking, with the AQ and RAADS-R being too long, unwieldy and time consuming for the 
psychiatric patient to complete and the short version of AQ, AQ-10, having insufficient 
evidence for screening in psychiatric settings. 
1.5.1.2 Sex differences in the differential diagnostics 
Diagnostic challenges differ in some ways between females and males. Male bias may 
increase the risk of a missed ASD diagnosis in females when symptoms are instead attributed 
to a comorbid, more female-biased diagnosis. This has been found for eating disorders, where 
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a large number of female patients present with signs of Asperger syndrome;
32,75
 it has also 
been suggested that anorexia in some cases may be a sign of an underlying ASD rather than a 
comorbidity.
76
 
1.5.1.3 Sex differences in autistic symptoms 
Owing to the history of describing Asperger syndrome or high functioning ASD as a male 
disorder, the diagnostic criteria for ASD are still based on the typical characteristics of a male 
with ASD. It has been suggested that ASD in females often goes unrecognized because of a 
presentation that differs from male-typical ASD and also from a greater ability to camouflage 
symptoms.
25,77
 Differences in presentation have been described in all three classical core 
symptom domains: the most well documented is the decreased number of restricted and 
repetitive patterns of behavior and interests,
78
 but characteristics more often described in 
females with ASD include a greater awareness of the need for social interaction, an ability to 
mask difficulties by imitating other’s behaviors, developmentally superior linguistic abilities, 
and superior imagination.
77,79
 
Additionally, there are indications of male-biased diagnosis of boys and girls with the same 
symptom burden: 1) males are, on average, diagnosed at an earlier age,
80
 even when boys and 
girls present with similar amounts of autistic traits,
81
 2) a study comparing children with 
equal levels of ASD traits that had either received an ASD diagnosis or not, showed that girls, 
but not boys, who meet diagnostic criteria for ASD show lower intellectual level and more 
behavioral problems than their non-diagnosed peers with similar levels of ASD traits.
82
 
 
1.6 EXPLAINING THE MALE PREDOMINANCE 
The male:female ratio of ASD has been estimated to 4-5:1, but varies from 2:1 in cohorts 
with low intellectual quotient (IQ) to 7:1 in high functioning cohorts.
83
 Several non-mutually 
exclusive explanations for male predominance have been put forward, some focusing on an 
over-estimation of the male:female ratio and others suggesting biological models based on 
male-biased risk-factors and a female protective factors. 
As previously mentioned, it has been suggested that the diagnostic process leads to 
underdiagnosis of females due to phenotypic differences for males and females with ASD
25,77
 
and a male biased diagnostic assessment discriminating females from ASD diagnoses even 
when criteria are met.
80–82
  
The prenatal testosterone hypothesis of the EMB males supports the idea that males are more 
exposed to the risk factors for ASD. Furthermore, biological differences between the sexes 
may also contribute to a female protective effect, that is, biological factors specific for the 
female sex which counteract the effects of risk factors for ASD. This protective effect has 
recently been suggested to relate to sex-differences in neural plasticity at the synaptic and 
regional level.
84
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Several biological explanation models have been proposed and tested, and are more 
thoroughly reviewed by Lai et al.
85
 Although there is no support for one single female 
protective genetic factor that could explain the sex bias,
86
 there is evidence that females 
require a greater genetic burden to surpass the diagnostic threshold for an ASD diagnosis. The 
multifactorial model of disease transmission suggests that genetic liability for autism is 
normally distributed in the population and that there exists a minimum level of genetic 
liability causing ASD that is higher in females than in males.
87,88
 A register study of siblings 
to probands with autistic impairments in the top 90
th
 percentile found significantly more 
autistic impairments in siblings of female probands with autism than in siblings of male 
probands, indicating that a larger etiological load is required for females.
89
  
A variant of this model explains differences in genetic liability between males and females 
with a qualitative difference in the etiological factors for ASD in males and females. One 
large genetic study found that de novo mutations more often lead to sporadic ASD in males 
than in females, but that the off-spring of the non-symptomatic females present with 
increased risk for familial ASD.
90
 This suggests that de novo mutations have elevated 
penetrance in males compared with females, which is also supported by several genetic 
analyses of individuals with ASD showing a larger number of large de novo copy number 
variations (CNVs) in females than in males,
91,92
 indicating different thresholds in males and 
females for developing symptoms. 
A revision of this completely genetic view is the multi-factorial sex/gender-differential 
liability model. In this model, an etiological burden is added to the genetic load, suggesting a 
common genetic threshold; however, the liability distribution for the entire sex is shifted 
towards (in males) or away from (in females) this threshold by sex-differentiated genetic or 
environmental factors, e.g. an X chromosome protective effect or elevated risk by increased 
levels of prenatal androgens. Support for protective genes on the X-chromosome is indicated 
by the increased prevalence of autism in X-linked disorders like Turner syndrome (X0),
93,94
 
fragile-X syndrome (an absence or mutation of the FMR1 gene on the X chromosome)
95
 and 
Rett syndrome (mutations of the MECP2-gene on the X chromosome).
96
 On a slightly 
different note, an intricate gene by environment interaction has been proposed by Hu et al:
97
 a 
deficiency in the expression of the retinoic acid-related orphan receptor alpha (RORA) gene in 
ASD causes dysregulated feedback loops with both sex hormones as well as the expression of 
several other genes related to ASD
35,98
 and RORA dysfunction may have different impacts on 
males and females with ASD.
97
 
1.7 SEX/GENDER DIFFERENCES IN BEHAVIOR 
Although behavioral differences between human males and females are diffuse and by no 
means applicable on individual level, a range of differences have been measured on group 
level, and some already in infants. The largest behavioral differences are found in sexual 
preference (over 90% of adults report sexual attraction toward the opposite sex) and gender 
identity. Smaller differences have been found in empathy
99
 and verbal fluency,
100,101
 where 
females outperform males, and males generally express more physically aggressive 
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behavior
102
 and proficiency in mental rotation than females.
103
 Sexual desire is also generally 
higher in men.
104
 The differences may be X-or Y-chromosome linked or dependent on 
prenatal as well as post-natal circulating hormone levels, but to some extent, they can also be 
socially determined. The term sex/gender is used to acknowledge the overlap between 
biological and social effects on behavior and, consequently, the difficulties to fully 
distinguish the effects. 
1.7.1 Fetal sexual differentiation 
The gonads develop in the sixth week of pregnancy. Testicles are developed if the sex 
determining gene on the Y chromosome (SRY) is present. When developed, the testicles start 
producing testosterone in a surge that lasts until gestational week 24. A sufficiently high level 
of testosterone is then essential for the formation of male genitals during the sexual organ 
development between gestational weeks 6 and 12. In the absence of sufficient testosterone 
exposure, female genitals form. Brain development is also affected by sex hormones. Both 
testosterone and estrogens are said to have organizational effects on the brain because they 
produce permanent changes to brain structures.  
1.7.2 Prenatal testosterone and behavior 
1.7.2.1 Animal studies 
Studies on non-human mammals, from rodents to primates, have shown that prenatal 
testosterone levels influence sexual differentiation of the brain that will impact behavior.
105
 
Testosterone and its derivative estradiol have been shown to affect cell survival and neurite 
outgrowth. Early hormonal manipulation in animals has shown effects of testosterone on the 
development of neural regions resulting in altered patterns of apoptosis, connections between 
neural regions and neurochemical sensitivity.
106
 Sex dimorphic behavior affected by the same 
hormonal manipulations, such as sexual behavior, aggressive behavior and juvenile rough-
and-tumble play, are thought to be an effect of these neural changes.
106
 
1.7.2.2 Human studies 
The research on sex differences related to prenatal testosterone levels is complicated by 
difficulties in direct measurement of prenatal testosterone. The effects of high prenatal 
testosterone levels have therefore been studied in indirect ways. Congenital adrenal 
hyperplasia (CAH) is a rare genetic disease resulting in elevated androgen production in the 
adrenal glands. Comparisons between females with and without this condition show effects 
of elevated prenatal testosterone regarding increased male-typical toy, playmate and activity 
preferences.
107
 Prenatal exposure to testosterone has been found to correlate positively with 
aggression
47,108,109
 and negatively with empathy.
110,111
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1.8 ASSESSING PRENATAL TESTOSTERONE EXPOSURE 
Several methods have been used to estimate prenatal testosterone exposure, the most 
common of which are measurements of testosterone levels in amniotic fluid (during 
pregnancy), umbilical cord blood (at birth) and using sex-dimorphic biomarkers as postnatal 
surrogate measures.
112
 The effects of prenatal testosterone exposure on group level may also 
be studied in persons exposed to elevated levels of testosterone due to a known condition. 
1.8.1 2D:4D 
The ratio between the second and fourth digit lengths (2D:4D) is a sex-dimorphic measure 
widely used as a surrogate measure for fetal testosterone levels in the first trimester.
112
 Sex 
differences in 2D:4D, showing a lower ratio in boys than in girls, have been detectable from 
10 weeks and older,
113
 with some variation of magnitude over time.
114,115
 Females and males 
exposed to elevated levels of prenatal androgen due to CAH have lower 2D:4D
116,117
 and 
males with complete androgen insensitivity syndrome (CAIS) have larger 2D:4D than same-
sex controls indicating that this sex-dimorphism is in fact related to prenatal androgen 
exposure. Several studies have found a decreased 2D:4D in the ASD group.
118
 
The usefulness of this measure as a surrogate for prenatal testosterone exposure has recently 
been questioned, noting that differences are small, with a large overlap between compared 
groups and sexes and thus do not reflect a linear or even a monotonically increasing 
relationship between 2D:4D and prenatal testosterone levels.
114
  
 
1.8.2 Testosterone transfer  
In animal studies, testosterone has been shown to 
transfer from male fetuses to adjacent fetuses via 
amniotic diffusion causing elevated levels of 
testosterone and masculinization in female fetuses.
119
 It 
has been suggested that this phenomenon also occurs in 
human multiple pregnancies,
120–122
 implying that 
comparisons of masculinization of sex-differentiated 
traits in female dizygotic (DZ) twins with either a male 
co-twin increasing prenatal testosterone exposure or a 
female co-twin not affecting testosterone levels, may 
shed light on the effects of elevated prenatal 
testosterone levels (Figure 1).   
 
 
Figure 1 The testosterone transfer 
theory proposes that testosterone 
exposure through amniotic diffusion 
from a dizygotic male twin may cause 
masculinized characteristics in his 
female twin. 
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1.9 GENDER RELATED OBSERVATIONS IN AUTISM SPECTRUM DISORDER 
A straightforward assumption along the prenatal testosterone hypothesis of the EMB would 
be that all patients with ASD have been exposed to additional prenatal testosterone during the 
entire sex-differentiation developmental process. If this is the case, all sex-dimorphic 
characteristics assumed to be differentiated in the fetus should be masculinized in people with 
ASD. Contrary to this conclusion, however, clinicians have observed that demasculinized 
appearance and behavior in males with ASD appear to be more frequent than in the general 
population.  
1.9.1 Gender identity 
Reports from clinics as well as studies indicate that the prevalence of ASD is increased 
among patients with gender identity disorders.
123
 Preliminary data from the Swedish 
diagnosis register showed a 14% prevalence of ASD diagnoses among 18-24 year old 
individuals with a transsexualism (ICD-10 F64) diagnosis in 2010 (Kosidou Kyriaki, 
unpublished). 
1.9.2 Gender appearance 
Although individuals with ASD, as well as the general population, show great variability in 
physical appearance, clinical observations of ASD patients have suggested a larger 
prevalence of obesity
125,126
 as well as an overrepresentation of physical features with an 
androgynous appearance, e.g. slenderness, delicate facial features and high pitched voices in 
male ASD patients.
4,5
 Notably, this phenotype has not been described in female ASD 
patients.  
 
1.10 SEXUALITY AND AUTISM SPECTRUM DISORDER 
There is a paucity of studies concerning sexual orientation and sexual behavior in adolescents 
and adults with ASD. The core autistic traits indicate that sexual behavior and experience 
could be different in this group: difficulties with social relationships may complicate forming 
and maintaining romantic relationships, preoccupation with a special interest as well as the 
common resistance to touch, probably caused by a combination of hyper sensitivity and 
impairments concerning social relations, could potentially leave little space for interest in sex 
or romance and may be difficult to overcome. At the same time, presumed elevated levels of 
prenatal testosterone in ASD would potentially impact sexual behavior and orientation. 
Autobiographies and case studies of adults with ASD have indicated an existing romantic and 
sexual interest in many individuals with ASD,
127–129
 but also higher frequencies of 
asexuality.
48,130
 Higher rates of bisexuality have also been indicated.
129,130
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1.11 SEX HORMONES IN THE ADULT 
Appearance and sexuality in adults is also affected by circulating sex hormones. Androgens, 
which bind to the androgen receptor (AR) are the sex hormones largely affecting male 
characteristics while estrogens, which bind to the estrogen receptor (ER), affect female 
characteristics. Both hormones are present in both sexes, together with a large amount of 
related hormones and precursors.  
Sex hormone-binding globulin (SHBG) is important in the regulation of androgens and 
estrogens. It is synthesized in the liver and binds to androgens such as testosterone and 
estrogen in blood, regulating their accessibility to target cells. SHBG production is regulated 
by both hormonal and nutritional factors, and has been shown to increase during estrogen 
treatment and decrease after androgen administration.
131
 Obesity is associated with decreased 
SHBG levels in both sexes, mainly due to increased liver fat.  
Dehydroepiandrosterone sulphate (DHEAS) is an androgen mainly produced by the adrenal 
glands, but also in the gonads and brain. DHEAS must be converted to testosterone to affect 
AR. Its production varies with age: the fetal adrenal cortex secretes large amounts of 
DHEAS, however, after birth, DHEAS serum concentrations quickly decrease to very low 
levels. At the adrenarche at about age 7, DHEAS levels start increasing again and peak in the 
20s-30s, followed by a steady decline with age.  
Androstendion (A) is produced both by the gonads and the adrenal cortex. CAH leads to 
increased production of A due to 21-hydroxylase deficiency. In peripheral tissue, A is 
converted to testosterone, but can also be aromatized to estrogen. 
Testosterone (T) is the most potent androgen. In men, it is mainly produced in the testes, but 
in women T is secreted by the adrenal cortex (25%) and the ovaries (25%), the remainder is 
produced peripherally from circulating DHEAS.
132
 Circulating levels are in the range 0.6–
2.5nmol/L. Testosterone concentrations vary during the menstrual cycle and reach a lowest 
point in the early follicular phase of the cycle, rising to a mid-cycle peak with luteal phase 
concentrations higher than those of the early follicular phase.
133
 
Estradiol is the most potent and most abundant estrogen. In women, estradiol is mainly 
produced in the ovaries, and estradiol levels vary over the menstrual cycle. In men, T is 
converted to estradiol by the enzyme aromatase which, together with ER are abundant in 
brain regions related to sexual arousal, the penis and the testes. Estradiol has also been shown 
to modulate libido and erectile function in men.
134
 
1.11.1 Sex hormones in autism spectrum disorder 
Adolescent and adult levels of sex hormones in ASD have not been thoroughly studied; 
however, it has been indicated that increased serum levels of sex hormones and steroidopathy 
diagnoses are more common in women with ASD.
45,135,136
 In men with ASD, studies are few 
and small and show no conclusive results.
135–137
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2 RATIONALE AND AIMS OF THIS THESIS 
The extreme male brain theory of autism describes ASD as being characterized by an extreme 
male intellect and suggests that elevated levels of prenatal androgens may play an important 
role in the development of autism. There is support for a masculinization of the brain from 
structural and functional imaging studies as well as studies showing a correlation between 
elevated prenatal testosterone and increased number of autistic traits; however, some 
questions remain regarding to what extent prenatal testosterone or other lesser known sex-
differentiating etiological factors are involved the development of ASD and through which 
mechanisms (e.g. fetal overproduction as in CAH, external testosterone exposure from 
mother with PCOS or a male twin; or gene-environment interactions such as dysregulated 
expression of the sex-dimorphic RORA gene).  
Clinical observations have indicated a tendency for androgynous physical traits in males with 
ASD. Along the same vein, transgender clinics and self-biographical reports from individuals 
with ASD have indicated a weak gender identity and higher frequencies of asexuality and 
non-normative sexual orientation.
129
 A better understanding of how traits beyond the extreme 
male cognition relates to typically developed males and females may add a new perspective 
to the sex/gender-related aspects of ASD, possibly providing evidence for a connection 
between androgens and ASD.  
Studies I and II aim to study sex-differentiation in ASD beyond masculinization in 
systemizing and empathizing presented by the extreme male brain theory. Study III further 
attempts to test the prenatal testosterone hypothesis in ASD by examining whether female 
fetuses exposed to elevated levels of prenatal testosterone from a twin brother develop an 
increased number of autistic traits. 
Study IV acknowledges the problem with identifying a previously unrecognized ASD in 
adult psychiatric patients. As underdiagnosis of ASD in females is believed to be a reason for 
the greater male:female ratio observed in high functioning ASD, additional instruments that 
aid the psychiatric differential diagnostics are necessary to counteract missed diagnoses. A 
short self-assessment instrument provides valuable, time-efficient screening for evaluation of 
the need for further investigation of a possible ASD. Recognizing a previously undiagnosed 
ASD in adult psychiatric patients may aid in treatment choices and allow adapted support, as 
well as increase self-acceptance. 
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2.1.1 Aims 
Study I 
To assess sex-dimorphic physical measures purportedly related to the prenatal androgen 
influence in men and women with and without ASD to shed further light on its possible 
biological underpinnings. 
Study II 
To explore psychological factors related to prenatal androgen influence, such as gender self-
perception, gender role and sexuality in men and women with and without ASD.  
Study III 
To test the theory that prenatal testosterone increases autistic and ADHD traits by comparing 
the number of autistic and ADHD traits in DZ index twins with a female co-twin to those in 
DZ index-twins with a male co-twin. 
Study IV 
To examine the validity of the RAADS-14 Screen in a psychiatric population and to 
determine any sex-related differences. 
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3 MATERIALS AND METHODS 
This thesis encompasses several different study designs: studies I and II are based on the 
same case-control study, analyzing sex/gender-dimorphic characteristics, study III is based on 
parent-reported data from a twin register, and study IV is a psychometric evaluation of a self-
assessment questionnaire comprising anonymously collected questionnaire data. 
Table 1 Summary of aims, participants and methods in studies I-IV. 
Study Aim Participants Methods 
I Explore differences 
in sex-dimorphic 
physical features 
between men and 
women with and 
without ASD. 
Case-control-study: 
50 adults with ASD 
(26 men and 24 
women) 
53 gender and age 
matched controls 
without ASD (28 men 
and 25 women). 
Sex/gender separated comparisons 
of: anthropomorphic measures, 
serum hormone levels and blinded 
assessments of face, body and 
voice characteristics from 
photographs and recordings. 
II Explore differences 
in gender role, 
gender identity, 
gender typical 
childhood behavior 
and sexuality in men 
and women with and 
without ASD. 
Sex/gender separated comparisons 
of: gender identity, gender role 
behavior and sexuality in ASD vs 
controls, using self-assessment 
questionnaires and interview. 
III Test effect of 
prenatal testosterone 
transfer on autistic 
and ADHD traits in 
DZ twins. 
Register study: 
Dizygotic twins aged 
9 or 12. 
8477 males. 
 
7835 females. 
Using data from the Child and 
Adolescent Twin Study in Sweden 
(CATSS). 
Comparison of A-TAC scores 
between index-twins with either a 
female or a male co-twin.  
IV Psychometric 
validation of the 
RAADS-14 Screen, 
including analysis of 
differences between 
diagnosis groups and 
genders. 
Psychometric study: 
135 adults with ASD. 
508 psychiatric 
controls. 
590 non-psychiatric 
controls 
Psychiatric and non-psychiatric 
participants completed the 
RAADS-14 Screen questionnaire. 
Analyses included construct 
validity, factor analysis, ROC-
analyses, and group comparisons 
for diagnosis and gender. 
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3.1 PARTICIPANTS AND PROCEDURE 
 
3.1.1 Studies I and II 
Studies I and II were based on the same case control study material. The study started in 
November 2006 and selection of measures and procedures as well as assessment of 
participants in the ASD group was performed by Susanne Bejerot and Sabina Bonde. I joined 
the work in May 2009, and co-jointly assessed the three remaining participants in the ASD 
group together with Dr. Bejerot and subsequently recruited and assessed the control group.  
3.1.1.1 Participants 
Fifty adults, (24 women, 26 men) diagnosed with ASD and 53 controls (28 men, 26 women) 
matched for sex and age were included in this study. 
Inclusion criteria for both groups were participants aged between 20 and 47 years who had 
parents of Swedish/White descent. The latter was to simplify masculinity/femininity 
assessment and to avoid possible variation due to cultural differences. Exclusion criteria were 
any known neurological or genetic syndrome, any disease or medication affecting androgen 
status, any congenital syndrome, diagnosed malformations, any psychotic episodes, 
intellectual disability or having attended special education in school up until ninth grade. 
Intelligence within the normal range was assumed by mainstream schooling. Exclusion 
criteria in the control group were a diagnosis of ASD or ASD in a first-degree family 
member, as well as large or multiple tattoos or piercings, in order to match the ASD group. 
All participants negated use of anabolic steroids or other androgen treatment. Hormonal 
contraceptive treatment was accepted.  
Participants were recruited through advertisements via a number of channels. The ASD group 
was recruited through an outpatient tertiary psychiatric unit for adults with ASD (n=20), 
Asperger Center - a community-based center for adults with ASD (n=24), and through a 
website for adults with ASD (n=6). Figure 2 illustrates the recruitment process of the ASD 
group. All controls were recruited through flyers posted on bulletin boards at a non-profit 
keep-fit organization (Friskis & Svettis: n=23), Stockholm University (n=8), student 
accommodation houses (n=5), at dental clinics and vaccination centers (n=5), private 
companies (n=4), employment agencies (n=2) or by referral from friends (n=7). 
3.1.1.2 Procedure 
An initial telephone screening was conducted for each participant to assess inclusion and 
exclusion criteria. Information about the study and screening questionnaires were mailed to 
the participants before assessment sessions. In the ASD group, the assessment session started 
with an ADOS assessment to evaluate if the participant fulfilled ASD criteria. The remaining 
assessment procedure was identical for the ASD and control groups: 1) interview questions to 
collect background data, childhood gender behavior and psychiatric structural interviews e.g. 
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MINI assessment; 2) physical examination and photography; and 3) completion of additional 
self-evaluation questionnaires. The participants were also given a referral for a blood test, and 
were instructed to take the test between 9:00AM and 13:00 PM.  
 
Figure 2 Recruitment flow chart: inclusion and exclusion of individuals with ASD in studies I and II. 
3.1.1.3 Laboratory tests and adjustments 
Blood samples for T, SHBG and DHEAS were collected between 9:00 AM and 13.20 PM. 
Due to the diurnal variability of male T,
138
 T samples are most stable between 7:00 and 9:00 
AM, after which stability declines. However, test times were fairly equally distributed in both 
groups and linear adjustment for the time of sampling in accordance with the results of 
Brambilla et al.
138
 did not markedly affect the outcome of the analyses. Female testosterone 
has less diurnal variation, but there is some variation over the menstrual cycle, peaking at 
ovulation.
139
  
The analyses of male and female T levels were conducted using both original data and data 
adjusted linearly for diurnal variation in men and days from ovulation in women. 
Additionally, as five women in the ASD group had body mass index (BMI) > 30 kg/m
2 
(classified as obese) and obesity is associated with decreased levels of SHBG in serum as 
well as elevated levels of androgen,
140,141
 we also analyzed the female groups excluding the 
obese women. 
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3.1.1.4 Anthropometrics  
The circumference of the head, chest, waist, hips, ankles and wrists were measured with a 
regular millimeter tape-measure. A participant stated height was accepted. If the participant 
was unsure, the height was measured with millimeter precision stadiometer. Because of the 
large difference in BMI between the female ASD group and controls, that affected 
anthropometric measures (wrist, ankle and waist-hip ratio) as well as androgen levels, 
analyses were conducted after linear adjustment for BMI. 
3.1.1.5 Digit ratio (2D:4D) 
The second and fourth digits of both hands were measured, fingers fully extended, from the 
middle of the proximal crease to the fingertip using a Vernier caliper. The 2D:4D is the ratio 
between the second and the fourth digit measures of each hand. 
3.1.1.6 Calibration of anthropomorphic measurements 
As body measurements were conducted by three different assessors, a calibration assessment 
was conducted where eight people who were not included in the study were independently 
measured by all raters, yielding an inter-rater reliability of 0.96-1.0 (Cronbach’s ). 
3.1.1.7 Gender coherence assessment 
Gender coherence in face, body and voice characteristics 
was blindly and independently assessed from 
photographs and voice recordings by a group of eight 
assessors.  
Voice samples were recorded with an analogue dictation 
machine while each participant read the same short story. 
The recordings were digitalized and normalized in 
volume before the assessment session.  
Face and body photographs were taken both front-facing 
and in profile, full-body with the participants in 
undergarments, in a standardized manner against a white 
background in the same examination room (Figure 3). To 
avoid distraction from hair and hairstyle, participants’ 
head hair was covered by a shower hat. Noticeable 
makeup and jewelry were removed before photographing. 
To minimize judgement bias due to the undergarments worn, photos were digitally 
manipulated to show a similar neutral shape and color of underpants and, for women, bra.  
Body and facial photos as well as voice recordings were assessed individually by eight 
independent assessors (four men and four women) aged 18-47 years who were selected to 
represent different ages and socioeconomic backgrounds. 
Figure 3 Body photos for gender 
coherence assessment (published 
with the consent of the participant). 
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The assessors were carefully instructed to estimate each participant’s gender typical features 
without judging beauty. Face, body, and voice were assessed separately. Femininity in the 
females and masculinity in the males were rated in accordance with a five-point Likert scale 
of gender coherence (for women: 1 = very feminine; 2 = more feminine than average; 3 = 
average; 4 = less feminine than average; 5 = a lot less feminine than average). 
Assessments were conducted on a computer for one gender at a time and in separate sessions 
for faces, bodies and voices. Within each session, and for each assessor, the order of the 
participants was randomized to minimize bias due to order or preconceptions from a 
previously assessed photo.  
Inter-rater reliability was calculated using Cronbach’s Alpha and was found satisfactory: face 
gender congruence  = 0.88, body gender congruence  = 0.86, and voice gender congruence 
 = 0.86 (average inter-item correlations were between 0.46 and 0.49). These -values did 
not increase when any evaluator’s results were disregarded. A month later, a subset of the 
photos was re-evaluated by six persons in the assessor group, likewise showing satisfactory 
intra-rater reliability. 
3.1.1.8 Sexuality questionnaire (Study II) 
The questionnaire regarding sexuality was a compilation of questions about sexual 
orientation, sexual experience and libido, as well as romantic partnership and was constructed 
specifically for this study because existing questionnaires were lengthy and had ambiguously 
worded questions assumed to render problems for individuals with ASD.  
Sexual orientation was examined with the question: “Whom are you attracted to?” The five 
response alternatives: “Men”, “Women”, “Both men and women”, “Neither”, and “Other” 
were dichotomized for heteronormativity, that is, opposite sex vs. any other response. 
Sexual experience and libido were examined with the question: “Age of sexual debut?” and 
five questions with multiple response alternatives, as shown in Table 2. Multiple choice 
alternatives were dichotomized for low and high sexual interest in the analysis. Additional 
questions regarding partnership were: “Do you have a partner?” and “Do you appreciate 
physical contact with a partner?” Seven questions in the questionnaire were discarded. These 
questions and reasons for discarding them are presented in Table 3. 
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Table 2 Included questions regarding sexual experience and libido from the sexuality questionnaire in 
study II. The responses were dichotomized into lower and higher sexual interest. 
Measure Item Response alternatives 
  Sexual interest 
  Lower Higher 
Intercourse Have you had sexual intercourse? “No” “Yes” 
Libido Have you been sexually aroused the 
past month? 
“No”,  
“1–3 times” 
“4–6 times”,  
“7–15 times”, 
“Every day” 
Sexual 
initiative 
Who takes initiative to have sex? “No one” 
“Partner” 
“Both”,  
“I” 
Sexual 
interest 
Are you interested in sex? “No, not at all”, 
“Not very much” 
“Yes, quite”, 
“Very interested” 
Orgasm 
frequency 
Have you had an orgasm during the 
past month? 
“No”,  
“1-3 times” 
“4-6 times”,  
“7-15 times”,  
“Every day” 
 
Table 3 Discarded items from the sexuality questionnaire in study II. 
Item Reason for discarding 
When did you enter puberty? Participants could not respond with certainty. 
How many sex partners have 
you had? 
Free-text answer could not be analyzed. 
How often do you think 
about sex? 
Free-text answer could not be analyzed. 
How many times have you 
had sexual intercourse during 
the past month? 
Answers were biased by having a partner and possibly by 
time of year. Most controls were interviewed during summer 
while interviews of persons in the ASD group were 
conducted year-round. 
How many times have you 
masturbated the past month? 
Variation depended on whether the respondent had a partner.  
Are you sexually aroused by 
something else than by 
humans, e.g. certain clothing, 
latex or something else? 
Free text answers. Difficult to analyze with a masculinization 
perspective. 
Sexual experience with same 
sex? 
Ambiguous definition of sexual experience and may have 
reasons other than personal sexual attraction, e.g. sexual 
assault or coercion. 
  
3.1.2 Study III 
3.1.2.1 Participants 
Study III used registry data of parent-rated neurodevelopmental traits from 16312 DZ twins, 
including 8477 males and 7835 females (Table 4), from the Child and Adolescent Twin 
Study in Sweden (CATSS), a Swedish twin registry.  
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The CATSS is an ongoing study on mental health problems that aims to track all twins born 
in Sweden since 1992. Parental assessment of the twins was conducted via telephone 
interview proximal to a child’s ninth birthday. During the first three years of the CATSS, 
interviews were also conducted for parents of 12-year-old twins to increase the number of 
included birth cohorts. The CATSS response rate is 80% and the presence of 
neurodevelopmental disorders has little influence on the response rate.
142
 Zygosity in all 
twins is determined by a DNA test.
143
 
Table 4 Number of same-sex and opposite sex dizygotic twins and their age distribution in study III. 
 No. of pairs No. of 9-year old pairs No. of 12-year old pairs 
Same sex 3937 2799 1137 
 Male 2129
†
 1503 625 
 Female 1808 1296 512 
Opposite sex 4219 3175 1044 
†
Assessment age data missing for one pair. 
3.1.2.2 Procedure 
This study examined the effects of elevated prenatal testosterone levels in girls on 
neurodevelopmental traits. The study is based on the assumption that testosterone diffuses 
from male to female fetuses sharing a womb, as postulated by the testosterone transfer theory. 
In the light of this, having a male co-twin should cause elevated testosterone levels in female 
twins. We tested whether female DZ twins with a male co-twin have more autistic and/or 
ADHD traits than a female DZ twin with a female co-twin. 
Data on neurodevelopmental traits in DZ twins were acquired from the CATSS study. Within 
the CATSS, data on neurodevelopmental traits was collected through the parental interview 
The Autism–Tics, AD/HD, and other Comorbidities inventory (A-TAC).  
Scores were compared between index-twins with a female co-twin and index-twins with a 
male co-twin and analyses were conducted separately for male and female index twins. The 
main analyses comprised the composite modules for ASD and ADHD. Additional sensitivity 
analyses were conducted for the five separate ASD and ADHD modules and, as comparison 
modules, for “perception”, which is also related to ASD and therefore possibly affected by 
prenatal testosterone, and for “emotion” and “opposition”, which are not assumed to be 
affected by prenatal testosterone levels (Table 5). 
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Table 5 A-TAC modules included in analyses in study III. 
Tested constructs A-TAC module 
ASD Language 
 
 
Flexibility 
Social Interaction 
ADHD Concentration/Attention 
 Impulsiveness/Activity 
Control modules Perception 
 Opposition
†
 
 Emotion
†
 
†
Not assumed to be affected by prenatal testosterone levels. 
3.1.3 Study IV 
3.1.3.1 Participants 
A total of 135 adults with ASD (64 men, 66 women), 508 adult psychiatric controls (191 
men, 280 women) and 590 non-psychiatric controls (105 men, 400 women, and 85 persons of 
unknown sex) participated by anonymously responding to the abridged RAADS-R 
questionnaire. Additionally, data comprising 75 adults with ASD and 197 non-psychiatric 
adults from the validation study of the Swedish RAADS-R
144
 was initially used to select 
items for the abridged questionnaire. Psychiatric participants were either patients recruited 
from 17 Swedish psychiatric outpatient clinics (n=541) or individuals responding to a web-
based survey advertised in online communities and targeted to people diagnosed with ADHD, 
Asperger’s disorder, social anxiety disorder and mood disorder (n=102). Only questionnaires 
endorsing that the respondent was diagnosed by a psychiatrist were included.  
A total of 89 individuals were excluded from phases II and III due to: 1) entering the study as 
a psychiatric participant but failing to report a confirmed diagnosis (n=40); 2) entering the 
study as a non-psychiatric control but reporting a psychiatric diagnosis (n=11); 3) having 
checked all items identically, indicating not reading the statements (failing to notice the 
reversed item: n=35); 4) five or more missing items; or 5) having a diagnosis of intellectual 
disability (n=1). 
3.1.3.2 Procedure 
This study was conducted in three phases: the first phase was performed by Lisa Andersen, 
using data from the Swedish RAADS-R validation study. In this phase, the 18 RAADS-R 
items that best distinguished ASD from controls in each subscale were selected. The second 
phase, which was performed as my master’s thesis project,145 was a pilot study testing the 18 
items of the abridged RAADS questionnaire in psychiatric outpatients and removing four 
items that failed to identify ASD in this population. Finally, the third phase, which is part of 
this thesis, validated the final RAADS-14 Screen in a psychiatric population comprising 77 
individuals with ASD and 370 individuals without ASD but with another psychiatric 
disorder, including mood disorder, psychotic disorder, anxiety disorder, borderline 
personality disorder and ADHD. Sex/gender differences were also studied. 
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3.2 ASSESSMENT INSTRUMENTS 
3.2.1 The Ritvo Autism and Asperger Diagnostic Scale-Revised (RAADS-R) 
(Studies I, II and IV) 
RAADS-R is a self-assessment instrument developed as an aid in the ASD diagnostic 
procedure in adults. The 80 item questionnaire assesses autistic traits with 60 items that 
closely match diagnostic criteria in the DSM-IV in the domains of “social interaction”, 
“language”, and “circumscribed interests”, and also including 20 items in the additional 
“sensory motor symptoms” domain added in the DSM-5. All items are statements formulated 
in the first person narrative. Examples of these items include: “Sometimes I offend others by 
saying what I am thinking, even if I don’t mean to”, “The phrase ‘I’ve got you under my skin’ 
makes me very uncomfortable”, and “Sometimes the sound of a word or a high pitched noise 
can be painful to my ears”. The four response alternatives “true now and when I was young”, 
“true only now”, ”true only when I was younger than 16” and “never true” are evaluated on 
a four-point Likert scale. Sixteen statements are reversely formulated to identify skills 
acquired during the life-span and to limit the effect of response bias.
146
 Good internal 
consistency has been shown for three of the subscales, while the internal consistency of the 
language subscale ranges from poor to acceptable.
67,144
 With its 80 items the RAADS-R is 
comprehensive and can take up to an hour to complete for people with psychiatric problems. 
Sex differences were tested in the Swedish RAADS-R validation study.
144
 Men and women 
diagnosed with ASD received equally high total scores but, in line with other research, 
women with ASD scored higher on the sensory motor subscale than men with ASD. The only 
subscale showing a significant sex-difference in the non-psychiatric comparison group was 
the language subscale where men reported more autistic traits. 
3.2.2 The Autism Spectrum Quotient (AQ) (Studies I and II) 
The Autism Spectrum Quotient (AQ) was used to examine the number of autistic traits in 
men and women in both the ASD and control groups. 
AQ was developed as an instrument to measure autistic traits in the general population.
69
 It 
consists of 50 items positively or negatively related to autistic traits designed to assess five 
different areas of functioning: social skills, communication, attention switching, attention to 
detail, and imagination, e.g. “I enjoy social chit-chat” and “I notice patterns in things all the 
time”. Each item is evaluated on a four-point Likert scale (“Definitely agree”, “Slightly 
agree”, “Slightly disagree” and “Definitely disagree”). Scoring is often dichotomized to 
symptom agreement. Several validation studies have shown good psychometric properties, 
however with varying internal consistency of the five-factor model.
69,147,148
 The instrument 
has good ASD screening properties in the normal population,
149
 but it has been shown that 
certain groups, e.g. mathematicians
69
 and individuals with schizophrenia
150
 score high on the 
AQ without having ASD. 
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3.2.3 Autism Diagnostic Observation Schedule (ADOS) (Studies I and II) 
ADOS module 4, is a semi-structured standardized observation instrument for adolescents or 
adults with fluent speech who are suspected of having ASD. It consists of several tasks and 
interview questions assessing autistic symptoms in terms of social interaction, 
communication, and imaginative use of materials.
151
 ADOS module 4 is widely used as a tool 
to confirm an ASD diagnosis and was used as such in Studies I and II.  
3.2.4 The MF-scale (Study II) 
The MF scale
152
 is a validated Swedish modification of the Bem Sex Role Inventory.
153
 It 
measures stereotypical masculine and feminine behavioral traits with 43 items rated on a 
four-point Likert scale (1 = “I totally disagree”, 2 = “I slightly disagree”, 3 = “I slightly 
agree” and 4 =”I fully agree”). Male and female stereotypes (defined in the two subscales 
MF-M and MF-F) are assessed with 17 items each, and a further nine items are considered 
gender neutral. The MF-M scale contains statements regarding power, assertiveness, 
leadership abilities and competitiveness, while the MF-F mainly measures how tender, caring 
and dismissive a person rates him-/herself. 
As Swedish gender norms have changed markedly since the development of the MF scale, we 
conducted a (yet unpublished) study to estimate how current masculine and feminine gender 
roles relate to the MF scale. A total of 637 Swedish-born adults (46% men and 54% women; 
age range 19–65 years) were recruited in conference halls and in public places in Stockholm. 
This study showed extant gender-differences with mean MF-M scores of 48.6 (6.3) for men 
and 45.3 (5.8) for women, and mean MF-F scores of 42.4 (4.8) for men and 46.4 (4.4) for 
women. 
3.2.5 The Mini-International Neuropsychiatric Interview (MINI)  
(Studies I and II) 
The Mini-International Neuropsychiatric Interview (MINI version 5.0.0.) is a validated 
structured interview to assess psychiatric disorders. It consists of modules that correspond to 
diagnostic categories according to the DSM-IV. It has been used in clinical settings as well as 
in research studies.
154
 
3.2.6 The Autism–Tics, AD/HD, and other Comorbidities inventory (A-TAC) 
(Study III) 
A-TAC is a telephone parental interview to assess neurodevelopmental traits in children. It 
consists of 20 modules assessing different clinically meaningful areas of neurodevelopmental 
problems with 96 questions that are largely based on the DSM-IV criteria for neuro-
psychiatric disorders. AD/HD traits are assessed with the two modules 
“impulsiveness/activity” and “concentration/attention”. The validated ASD assessment 
consists of the modules: “language”, “social interaction” and “flexibility” (mirroring the 
DSM–IV subdomain of “restricted repetitive and stereotyped patterns”). Additional modules 
in A-TAC are: the “perception” module, which assesses hypo-/hyper- reactivity to sensory 
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input and corresponds to the “hyper- or hypo-reactivity to sensory input” ASD criterion in 
DSM-5; and fourteen modules not closely related to ASD or ADHD: “emotion”, 
“opposition”, “learning”, “planning & organizing”, “memory”, ”tics”, “compulsions”, 
“feeding”, “separation”, “conduct”, “anxiety”, “mood”, “concept of reality”, and 
“miscellaneous”. 
 
3.3 STATISTICAL ANALYSES 
In all studies, comparisons of dichotomous variables were conducted using 2-test for 
significance analysis. Odds ratios and confidence intervals were included in study IV. Group 
means were compared using a Student’s t-test, and Cohen’s d for estimation of effect size. 
For heavily skewed data, a Mann–Whitney U test was used, with effect size calculated as r = 
𝑍/ √𝑁
155
 (the effect size is considered large for r ≥ 0.5, medium for 0.5 > r ≥ 0.3, and small 
for 0.3 > r ≥ 0.1). A two-tailed P value of < 0.05 was considered significant.  
In studies I and II, adjustments were applied to some measures before analysis: missing data 
on the MF subscales and the AQ were substituted with mean values of all the items in the 
respective subscale; linear adjustments were conducted to compensate for strong influence of 
BMI on the variables of waist, hip, ankle and wrist measure and testosterone level. Additional 
adjustments for diurnal testosterone variation in men and for menstrual variation in women 
were conducted. 
In study III, the A-TAC data was heavily skewed with over 50% of the participants scoring 0 
on either ASD or ADHD traits. For this reason, all analyses were conducted with non-
parametric methods. The effect of age was studied both with a Kolmogorov-Smirnov test 
comparing the distributions for the two age groups and with Quade’s rank analysis of 
covariance.
156
 The latter analysis was also used to study interaction of comorbid ASD or 
ADHD traits. 
Study IV used a receiver operating characteristic (ROC) curve to evaluate the discriminatory 
power of the scale: for each score, the rate of true positives (sensitivity) was plotted against 
the rate of false positives (1-specificity). The area under the curve (AUC) is a measure of the 
power to discriminate between ASD and non-ASD. An AUC > 0.7 is considered acceptable. 
Aiming to achieve good screening properties with high sensitivity, the cut-off score was 
selected by choosing the lowest score corresponding to a true positive rate of 93% or greater 
in the combined phase II and III samples. An alternative cut-off was selected by finding the 
score yielding the maximum (specificity + sensitivity). 
 
  
 26 
3.4 ETHICAL CONSIDERATIONS 
All studies were approved by the Regional Ethical Review Board at Karolinska Institutet, 
Stockholm. 
3.4.1 Studies I and II 
There are several ethical aspects to these studies. First, exposing individuals with ASD to 
being photographed in underwear and responding to intimate questions about sexuality and 
sexual orientation is sensitive and requires a clear ability to consent. Second, pointing out that 
ASD is deviant in a sex/gender perspective could possibly marginalize this group even more. 
However, these aspects of the study were described in the advertisement for participation and 
the study was thoroughly discussed and approved by the local empowerment board within the 
Swedish Autism Society (Autism & Aspergerförbundet). All participants provided written 
informed consent prior to study and information was given that indicated participation could 
be ceased at any time during the assessment session. Participants received a reimbursement of 
approximately £95.  
Participant ability to consent to the study was initially screened with a brief telephone 
interview ensuring that the individual had not been diagnosed with an intellectual disability 
and had attended mainstream schooling. None of the included participants had a caretaker or 
guardian. Further, in the ASD group, the ability to consent was also assessed by a psychiatrist 
during the initial interview. Three individuals that were deemed not to have the capacity to 
consent were subsequently excluded: two had a comorbid psychosis and one had epilepsy and 
brain damage.  
3.4.2 Study III 
All participation in the CATSS study is protected by the informed consent process – 
information is given about what data is being collected and participants can withdraw their 
consent and discontinue participation at any time.  
3.4.3 Study IV 
Information about the study was provided to all participants, who consented by completing 
the questionnaire. All questionnaires were collected without accompanying personal 
identification.  
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4 RESULTS 
 
Table 6 Summary of results 
Study Research hypothesis Results Conclusion 
Study I Persons with ASD 
display androgynous 
physical features.  
Elevated T levels and less 
feminine facial features 
were more common in 
women with ASD than in 
control women. Men with 
ASD showed less 
masculine body 
characteristics.  
Androgynous physical 
features are more 
common in adult males 
and females with ASD 
than in TD adults. 
Study II Individuals with ASD 
display an androgynous 
gender identity and 
gender role as well as 
atypical sexuality. 
Perceived gender 
typicality was shifted 
towards androgyny. 
Sexual interest was 
decreased in men and 
women with ASD as 
compared with TD men 
and women respectively.  
Despite their extreme 
male cognitive style, 
individuals with ASD 
show androgynous 
gender perception and 
demasculinized gender 
role and sexuality. 
Study III Female DZ twins have 
more traits of ASD and 
ADHD if they have a 
co-twin brother than if 
they have a co-twin 
sister. 
Parental reported scores 
of ASD and ADHD traits 
were lower in female DZ 
twins with a twin brother 
than in those with a twin 
sister. 
In female DZ twins, 
having a male co-twin is 
not associated with 
elevated traits of ASD 
and ADHD. 
Study IV RAADS-14 Screen 
shows good 
psychometric properties 
in psychiatric 
outpatients.  
The ASD group scored 
higher than all 
comparison groups. A 
cut-off score of 14 
yielded a sensitivity of 
97% and a specificity of 
46% in the ADHD group 
and 64% in patients with 
other psychiatric 
disorders. 
The RAADS-14 Screen 
is a promising measure 
for ASD screening in 
adult psychiatric 
outpatients. 
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4.1 STUDY I 
4.1.1 Anthropometric scores  
Women with ASD had significantly larger heads, higher BMIs and larger ankle 
circumferences and waist-hip ratios. However, differences in ankle measurement and waist-
hip ratio were not significant after adjusting for BMI. The men with ASD had higher 2D:4D 
ratios than control men (P = 0.04).  
4.1.2 Hormone levels 
Women with ASD had higher serum levels of both total and bioactive T than control women. 
Differences remained significant after excluding participants taking estrogen contraceptives 
and after adjusting for BMI. No differences were detected in serum T levels between male 
groups. The expected negative correlation between DHEAS and age could not be detected in 
men or women with ASD, but was observed in the control group. 
4.1.3 Gender coherence  
ASD men were assessed to be less masculine regarding body constitution (P < 0.001) and 
voice characteristics (P < 0.05) than control men, while facial features were regarded less 
feminine (P < 0.001) in women with ASD than in control women.  
 
4.2 STUDY II 
4.2.1 Gender identity, gender role and gender typical childhood behavior 
An atypical gender identity was more common in the ASD group than in the control group 
(2 (N=103) = 10.1; ϕ = 0.31; P = 0.001). When subdivided by sex, only the difference in 
women reached significance. More women with ASD than control women reported tomboy-
behavior as a child, while there was no difference in reported gender typical childhood 
behavior between male groups.  
Both men and women with ASD were less inclined to identify with masculine gender role 
traits and behavior than controls, as measured with the MF-M subscale. Within-group 
comparisons revealed similar scores for men and women with ASD on both masculine and 
feminine role identification whereas control men and women had similar scores for masculine 
role but not for feminine role identification. 
4.2.2 Sexual preference 
Sexual preference is presented in Table 7. Women with ASD reported higher non-
heterosexual preference than control women. No significant difference was detected in sexual 
preference between male groups. 
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4.2.3 Sexuality  
A total of 41% of the people in the ASD group reported having had sexual intercourse at least 
once in the previous month as compared with 79% in the control group. Notably, only two 
men (8%) and seven women (30%) in the ASD group reported having had sexual intercourse 
more than three times during that month – the number representing the median frequency in 
the control group. 
 
Table 7 Reported sexual preference in men and women with ASD and controls. 
 Men Women 
 ASD (n=26) Controls (n=28) ASD (n=24) Controls (n=25) 
Attracted to n (%) 
Men 2 (8) 2 (7) 9 (38) 21 (84) 
women 22 (85) 24 (86) 1 (4) 0 (0) 
both sexes 1 (3.5) 2 (7) 13 (54)
**
 4 (16) 
neither sex 1 (3.5) 0 (0) 1 (4) 0 (0) 
**
P < .01     
 
4.3 STUDY III 
4.3.1 Main results 
Female index-twins with a female co-twin were rated with a higher total ASD-score, (P = 
0.001; r = 0.04) than female twins with a male co-twin. The same difference was also 
significant in two of the three ASD sub-modules: social interaction (P = 0.01; r = 0.03) and 
flexibility (P = 0.005; r = 0.04) and also in the equally ASD related module perception (P = 
0.004; r = 0.04). 
Similarly, female index-twins with a female co-twin were rated with more ADHD-traits (P = 
0.03; r = 0.03) and specifically higher scores on concentration/attention (P = 0.001; r = 0.04) 
as compared with female twins with a male co-twin. 
No differences between boys on total ASD or ADHD scores were visible; however, in 
sensitivity analyses, boys with a female co-twin had higher rank scores on concentration 
/attention (P = 0.003; r = 0.04) and flexibility (P = 0.006; r = 0.03) suggesting poorer 
concentration ability and lower grade of flexibility, than boys with a male co-twin. 
4.4 STUDY IV 
Study IV examined the psychometric properties of the RAADS-14 Screen self-evaluation 
instrument, in terms of reliability and discriminative power. 
As the original RAADS-R was developed much in accordance with DSM-IV, two 
experienced clinicians were asked to independently map the RAADS-14 Screen items against 
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the DSM-5 criteria. The mapping was largely in unison and comprised all but one of the A 
and B criteria, excluding only the A4 stereotypy item that may be difficult for patients to self-
evaluate. 
4.4.1 Differences in total score 
The median score of the ASD group was 32 (range 8 – 42), compared with a score of 15 
(range 0 – 42; r = 0.5; P < 0.001), in the ADHD group and 11 (range 0 – 39; r = 0.7; P < 
0.001) in the Other psychiatric disorders group.  
4.4.2 Gender differences in scoring 
Table 8 shows median scores by gender. In the ASD group, there were only differences in the 
Sensory Reactivity domain where females scored higher. In the non-psychiatric group, males 
scored higher than females on both Mentalizing Deficits and Social Anxiety, but lower on 
Sensory Reactivity. 
 
Table 8 Median scores of the RAADS-14 Screen and subscales in men and in women 
 
4.4.3 Symptom perseverance 
Endorsement of symptom perseverance (childhood and adult symptoms) measured by a 
three-point item score is presented in Table 9. In the ASD group, 75% of the women and 57% 
of the men endorsed at least one persevering symptom from each domain (result not included 
in paper IV). 
 
 
Sample Sex n RAADS-14-
Screen 
Mentalizing  
Deficits 
Social 
Anxiety 
Sensory 
Reactivity 
   Median [min-max] 
ASD M 64 30 [0 - 42] 15 [0 - 21] 9.7 [0 - 12] 6 [0 - 9] 
  F 66 34 [9 - 42] 18 [3 - 21] 9 [0 - 12] 8 [3 - 9]
***
 
ADHD M 127 15 [0 - 36] 7 [0 - 21] 3 [0 - 12] 3 [0 - 9] 
  F 185 15 [0 - 42] 8 [0 - 21] 3 [0 - 12] 3 [0 - 9]
***
 
Other 
psychiatric 
M 64 11.5 [0 - 33] 4 [0 - 21] 4 [0 - 11] 2 [0 - 9] 
 Disorders F 95 12 [0 - 39] 5 [0 - 21] 2 [0 - 12] 3 [0 - 9] 
Non-psychiatric M 105 3 [0 - 19] 1 [0 - 13]
*
 1 [0 - 8]
**
 0 [0 - 6] 
  F 400 2.5 [0 - 28,7] 0 [0 - 18.7] 0 [0 - 10] 0 [0 - 9]
*
 
Samples selected from the combined phases II and III. 
*
P < .05, 
**
P < .01, 
***
P < .001; differences are indicated in the sex with the higher score. 
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Table 9 Percentage of participants who scored at least one three-point item score* in a RAADS-14 domain 
and in all three domains. 
 
4.4.4 Reliability and discriminatory powers of RAADS-14 Screen 
The RAADS-14 Screen showed excellent internal consistency between all 14 items (n = 
1,233,  = 0.9). The discriminatory power of the RAADS-14 Screen was 91% in ASD vs 
other psychiatric disorders and 88% in ASD vs ADHD. No differences were detected in 
reliability measures or discriminatory powers when analyses were split by gender. 
4.4.5 Cut-off scores 
A high sensitivity demand of 97% was reached with a cut-off score of 14 or above. This 
yielded a specificity of 46% in the group with ADHD and 64% in the other psychiatric 
disorders group.  
4.4.5.1 Additional results not presented in Paper IV 
A more conservative measure would be a cut-off of 23 points yielding 81% sensitivity and 
81% specificity out of the full psychiatric sample (Figure 4). 
Cut-offs regarding number of items endorsed with three-point score gave similar results: a 
cut-off of at least three three-point scores yielded 95% sensitivity and 37- 65% specificity. A 
cut-off of at least six three-point scores yielded 80% specificity and 70% sensitivity in the 
ADHD group and 76% sensitivity in the other psychiatric disorders groups.  
 
Sample Sex n Mentalizing  
Deficits 
Social 
Anxiety 
Sensory 
Reactivity 
All 
domains 
   % 
ASD M 64 82.1 89.6 65.7 56.7 
  F 66 84.1 92.8 89.9 75.4 
ADHD M 127 44.4 53.5 42.4 19.4 
  F 185 38.5 51.8 59.0 22.1 
Other 
psychiatric 
M 64 29.9 53.7 31.3 9.0 
disorders F 95 36.6 37.6 38.6 15.8 
Non-psychiatric M 105 7.6 18.1 12.4 0 
  F 400 7.8 14.0 13.3 0.5 
Samples from the combined phase II and phase III populations. 
*Three-point item score denotes endorsing a symptom both as adult and in childhood. 
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Figure 4 Sensitivity and specificity for the RAADS-14 Screen scores. A cut-off score ≥ 14 yielded a high 
sensitivity of 97% and a specificity of 46% in the ADHD group and 64% in the other psychiatric 
disorders group. A more conservative cut-off score ≥ 23 yielded a sensitivity of 81% and a specificity of 
81% in both the ADHD and other psychiatric disorders groups. 
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5 DISCUSSION 
This thesis takes on the subject of male preponderance for ASD using three different view-
points: studies I and II explored sex/gender differences and similarities beyond the extreme 
male cognitive style of ASD in men and women with and without ASD; study III estimated 
the effect on the development of autistic traits in female fetuses by prenatal testosterone 
exposure from a twin brother; and study IV introduced a new screening instrument for ASD 
in adults with co-occurring psychiatric symptoms, thus aiming to reduce underdiagnosis, 
which is believed to particularly affect females with a high functioning ASD. 
 
5.1 STUDIES I AND II 
The extreme male brain theory of autism explains the core cognitive symptoms of ASD with 
the combination of increased systemizing and decreased empathizing ability and attributes 
this to a hyper-masculinization of the brain that is suggested to be associated with elevated 
prenatal testosterone levels. While the extreme male brain phenotype seems like an all-
encompassing nature of ASD, masculinization in other known sex-dimorphic traits have 
appeared to be lacking in males but not in females with ASD. 
Studies I and II aimed to study sex-differentiation in men and women with ASD with regard 
to physical and mental characteristics beyond the masculinized cognitive functions presented 
by the extreme male brain theory. In line with clinical observations but in opposition to a 
straightforward interpretation of the effects of elevated prenatal testosterone in males, we 
hypothesized that male typical behavior and perception would be weakened in both men and 
women with ASD and that gender identity would be less pronounced, as compared with TD 
men and women respectively. 
5.1.1 Physical sex/gender differences  
The study of anthropometrics and circulating sex hormone levels in ASD men and women, as 
compared with TD adults showed great variability in both groups. The anthropomorphic 
measures showed few significant differences when comparing ASD and control groups for 
each gender: a larger head circumference in women with ASD and a higher 2D:4D in men 
with ASD. However blinded assessment of gender-typicality in face, body and voice showed 
larger amount of androgyny in the rater-assessed parameters in both men and women with 
ASD. These findings lend support to the clinical observations that initially gave rise to this 
study that androgynous features are more common in people with ASD, but that androgyny is 
not an all-encompassing ASD phenotype.  
In our study, we aimed to examine sex-differentiated characteristics affected by prenatal 
hormones, although the interpretation of the results also must account for pubertal hormones 
as well as hormonal effects of obesity. Our four group study design, comparing females and 
males separately, was unusual in ASD research at the time when the study was conducted and 
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the acknowledgement of the need for sex-differentiated studies describing the ASD group is 
an important strength of this study. This has later been underscored by Lai et al.
85
 
A somewhat surprising finding was that ASD men had an elevated 2D:4D as compared with 
control men, indicating a lower prenatal testosterone level in ASD men. This result differs 
from most previous studies that have found decreased 2D:4D in ASD.
118
 If 2D:4D were a 
reliable surrogate measure of prenatal testosterone exposure, this result would imply a very 
skewed recruitment of unusually masculinized control men or demasculinized ASD men. In a 
relatively small sample such as ours, this is possible; however, as the reliability of 2D:4D to 
predict prenatal testosterone has been found to be quite low
114
 our result could also be 
unrelated to prenatal testosterone levels. The most likely explanation is that this is a 
difference by chance, since the significance level was high (P < 0.05), and several other tests 
were performed, increasing the risk for chance findings. 
5.1.2 Gender identity and typicality 
In line with the results on physical appearance, the ASD group showed more androgyny with 
a less pronounced gender identity and a lack of difference in gender perception (“Do you 
perceive yourself as typical for your gender?”). Women with ASD more often reported being 
a tomboy as a child than control women. One could argue that such gender identification 
could be an effect of a weaker interest in gender aspects combined with a general feeling of 
being different, but the existence of an inherent sense of gender is supported by the strong 
feeling of being born with the wrong sex expressed by transgendered people. In the same 
vein, the overrepresentation of ASD in both male-to-females and female-to-males with 
gender identity disorder supports our findings of a gender identity shift towards androgyny. It 
has been suggested that transsexuality could be explained, at least to some extent, by opposite 
organizational effects during the different periods involved in sex-differentiated development 
of the genitals and the brain;
157
 for example, caused by a sudden change in prenatal hormone 
levels. If the sex-differentiation of the brain is continuously dependent on sex hormone levels, 
ASD could also be related to hormonal variability during fetal development.  
5.1.3 Gender role 
Identification with stereotypical masculine and feminine gender roles was measured with the 
two-dimensional MF-scale. Both ASD men and women showed a low identification with 
masculine role behavior (determination, strong leadership skills and competitiveness) as 
compared with control men and women respectively. With regard to female gender role 
behavior, no significant differences were detected between ASD and control groups in either 
sex. Interestingly, in the ASD group, no significant sex-difference was detected in the 
endorsement of masculine or feminine role behaviors. This gender role independence in ASD 
may be explained as a result of less organizational differences between men and women with 
ASD compared with TD men and women. In ASD the gender role is markedly 
demasculinized, as opposed to the masculinized pattern associated with empathizing-
systemizing, in men and women alike. Still, the lack of a difference in gender role may also 
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be an effect of an inherent indifference to gender roles, perhaps in combination with generally 
impaired functioning in ASD. Further studies using different gender role measures and a 
psychiatric comparison group may shed light on this. 
5.1.4 Sexuality 
Similarly to gender role behavior, sexual drive and behavior appeared demasculinized in both 
men and women with ASD. It should be noted that a subgroup of both men and women with 
ASD reported normal to high sexual activity and sexual interest; however, as a whole group, 
ASD men and women reported a later sexual debut and lower sexual activity. Low sexual 
interest and less inclination to take sexual initiative were also reported more often in the ASD 
group.  
Notably, eight individuals in the ASD group had not had their sexual debut, while this applied 
to none in the control group. There are several non-mutually exclusive explanations for this. 
First, a person with ASD has by definition impaired ability to from social relationships and 
many are socially withdrawn, creating obstacles to successfully approaching another person 
with romantic and/or sexual intent. Second, our findings of decreased libido and the 
experience of being asexual, also supported by self-biographical reports,
128,158,159
 are also 
possible explanatory factors for a delayed or absent sexual debut. Third, as the two hit 
model
160
 proposes adolescence as the second developmental hit for ASD causing limitations 
for the adolescent with ASD in the transition into an adult role and social demands on 
adaptive functioning, a delay in the adult transition may lead to a delayed sexual debut. Last, 
one can also speculate that, as non-normative sexual orientation and gender identity issues 
appear more common in the ASD group, this additional confusion may add to the difficulties 
mentioned above. 
5.1.5 Limitations and considerations 
There are several limitations to studies I and II that are worth considering. Recruitment of 
participants through advertisements will always increase the risk of selection bias. In this 
case, when the advertised theme was sex/gender differences and included being photographed 
in undergarments, blood-testing of sex-hormone levels and questions on sexuality, bias is 
unavoidable.  
Some effects of bias can be estimated by comparing our data with those of other comparable 
study samples: in a Swedish age-equivalent clinical sample of 45 men and 39 women 
diagnosed with high functioning ASD,
161
 cohabiting with a partner was equally as common 
as in this study. However, parenthood and university studies were only half as frequently 
reported in the clinical sample as in studies I and II, indicating that our sample was more 
socially adept and in some ways possibly less autistic than a random ASD sample. Thus, 
assuming that severity of symptoms is related to sex/gender characteristics also within the 
group diagnosed with ASD, our sample is expected to have less difference in characteristics 
than a random ASD sample. However, the relationship between severity of autistic traits 
within the ASD group and effect on sex/gender characteristics remains to be studied. At the 
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same time there are some indications that the control group was less gender typical than the 
general population: testosterone levels in the males were below the normal range and female 
controls scored higher on masculine behavior as measured by the MF scale than women in 
general. Together this could indicate that our data is actually an underestimation of 
differences. 
Another problem with the selection of participants is the etiological heterogeneity of ASD. 
The great variability in masculinization/demasculinization of physical and gender 
identification characteristics indicate effects on subgroups of ASD. As these differences also 
depend on factors un-related to ASD, a larger samples size is required to fully assess 
differences in masculinization of features and subgroup accordingly.  
There are also some limitations to the hormonal measures used in study I. There are 
uncertainties in male T measures due to diurnal variation, testosterone pulsatility and 
differences in physical activity before taking the blood test. Estrogen levels were 
unfortunately analyzed with insufficient sensitivity to detect differences in the low levels 
circulating in male blood. In females, sex hormone analyses have several uncertainties: sex 
hormonal variations over the menstrual cycle make subtle differences difficult to assess, and 
hormone levels are also affected by other factors such as obesity and hormonal 
contraceptives. However, excluding these groups was not an option as this would have 
increased selection bias.   
Finally there is a limitation to the ascertainment, as ADOS-interview was conducted with the 
controls. Two of the male controls had RAADS-R scores of 82 and 84 respectively, which 
are well above the suggested cut-off score of 66. As they were both reporting normal function 
they were included in in the control group for analyses. However, analyses excluding these 
two controls did not change the significances of the results. Notably, both males were rated 
less masculine than average.  
5.2 STUDY III 
The main aim of study III was to explore whether female fetuses exposed to elevated levels 
of prenatal testosterone from a twin brother develop an increased number of autistic traits, as 
the extreme male brain theory would predict. 
Since ASD and ADHD often co-occur, have male biased sex ratios and have been suggested 
to be connected with prenatal testosterone, our study comprised both disorders and similarly 
studied a set of other traits for comparison. Assuming that a dizygotic male twin fetus will 
expose it’s co-twin to increased testosterone levels we compared the amount of autistic and 
ADHD traits between dizygotic twin girls with either a twin brother (testosterone exposure 
from amniotic diffusion) or a twin sister (no additional testosterone exposure). 
Counter to our hypothesis, instead of finding increased autistic and ADHD traits in girls with 
a male co-twin as compared with girls with a female co-twin, the opposite result was found: 
traits of ASD and ADHD were more common in girls with a female co-twin than in girls with 
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a male co-twin. These differences were also present in all ASD-related modules except 
language. In the ADHD submodules, the difference was significant in the 
attention/concentration module but not in the impulsiveness/activity module. Interestingly, a 
higher rate of both boys and girls with a twin sister reached the lower cut-off for ADHD than 
those with a male co-twin.  
There may be several explanations for the paradoxical result that twins with a female co-twin 
receive higher scores on ADHD and ASD symptoms. First, when a parent assesses twins, 
there is a risk of contrast-effects resulting from an unconscious comparison between the 
twins. Contrast-effect means that an existing difference between the twins seems even larger 
to the rater (e.g. a twin girl with a (female-typically) low amount of autistic traits who has a 
twin brother with a (male-typically) slightly larger amount of autistic traits might be rated as 
having even less traits, while two twin sisters with the same amount of traits will be 
unaffected by contrast effects; Figure 5). As ASD and ADHD traits are somewhat more 
common in the boys, any existing contrast effects would be more likely to induce a decrease 
in the scores of girls with a twin brother than in girls with a twin sister. However, there is no 
current evidence for contrast effects in parent ratings of these traits and none were detected in 
the ratings of impulsiveness/activity, language, emotion or opposition, or sex-dimorphic traits 
that would be expected to be similarly affected by contrast effect. As parent ratings of traits 
are common in twin studies, contrast effects in the assessment of neurodevelopmental traits 
need further study. Second, underestimation of ADHD symptoms may be the result of greater 
social responsiveness in girls.
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 Finally, the possibility exists that testosterone exposure from 
a male twin is characterized by a dosage or timing that has a protective sensitizing effect for 
other testosterone exposures or dysregulations.
 
Figure 5 Contrast effect in twins: the observed difference in twin pair 1, results in affected parent ratings, 
amplifying the difference. Twin pair 2, lacking observable difference, will not be subject to contrast 
effects. 
5.2.1 Limitations and considerations 
Study III suffers from some limitations, first and foremost that the evidence for testosterone 
transfer in humans is not entirely clear, which makes it difficult to draw definitive 
conclusions regarding the lack of effect of the presumed elevated levels of prenatal 
testosterone.  
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There are also limitations is the assessment of neurodevelopmental symptoms using A-TAC. 
While parent assessment encompasses all types of situations and thus is based on more 
information than a clinician assessment, it is based on less knowledge of symptomatology 
and is more susceptible to contrast effects.
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 Furthermore, autistic traits are assumed to be 
normally distributed over the population but A-TAC shows a substantial floor effect. This 
means that any attempt to analyze the effect on neurodevelopmental traits in the whole 
population will be blunted by A-TAC’s insensitivity to detect differences in subtle traits in 
half of the population. 
 
5.3 STUDY IV 
Study IV assessed the validity of the RAADS-14 Screen, a short version of the self-
assessment questionnaire RAADS-R, in an adult psychiatric population without intellectual 
disability as well as in adults without a psychiatric diagnosis. The RAADS-14 Screen showed 
good psychometric properties and only takes a few minutes to complete, allowing for quick 
ASD screening in psychiatric outpatients. 
Individuals diagnosed with ASD endorsed more items than the other groups, reaching a 
median score of 32 as compared with 15 in the ADHD group, 11 in the other psychiatric 
disorders group and 3 in the non-psychiatric group. Endorsement of the response alternative 
indicating symptoms both as an adult and in childhood was also more common in the ASD 
group.  
As persevering symptoms with childhood onset is a necessary criterion for ASD, in contrast 
to most other psychiatric disorders with onsets in adulthood, another approach to evaluate the 
RAADS Screen questionnaire is to count the number of three-point scores, that is, the reports 
of life-long symptoms. The number of three-point scores proved an equally good screening 
criterion as total score. A combination of the two criteria, either two or more three-point 
scores or a total score > 12 provided an even higher sensitivity to the test; however, we assert 
that this adds too much complexity to the analysis for a clinical screening instrument. 
The broad heterogeneity of ASD causes difficulties in diagnosing cases with an atypical 
presentation because of co-morbid conditions or unusual compensatory abilities to mask 
impairments. A more common atypical presentation in females has also been suggested to 
lead to an underdiagnosis of high-functioning ASD in females. A correct identification of 
ASD in both males and females is important both in the clinical understanding and treatment 
of patients and as a basis for future research. No sex/gender differences in discrimination 
power of RAADS-14 Screen could be detected in this study sample. However, it is important 
to note that the women in our ASD sample had received a diagnosis and may not represent 
the group that is most difficult to recognize.  
Women scored higher than men in the Sensory Reactivity domain across all groups, 
supporting gender differences in sensitivity to noise and touch that have been previously 
  39 
reported.
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 TD men scored higher than women in the Mentalising Deficits and Social 
Anxiety domains. As sensory symptoms were more common in women than in men in the 
ASD group as well, the inclusion of sensory symptom items in the RAADS-14 Screen is an 
important strength in its screening ability in women. 
5.3.1 Limitations and considerations 
The RAADS-14 Screen showed a very good ability to distinguish between ASD and each of 
the tested psychiatric diagnoses with the exception of ADHD for which the specificity was 
marginally lower. The reasons for this are several: ADHD and ASD share persevering 
symptoms, which makes differentiating between the disorders inherently difficult, co-existing 
ASD and ADHD has been found to be very common
166
 and the ADHD sample included a 
number of patients who were later referred to a full ASD assessment, some of whom likely 
were diagnosed with ASD after our study was concluded. 
There are some limitations with regard to the study design. All diagnoses were based on 
patient/clinician reports, and no confirmative diagnostics or cross reference controls in patient 
charts were conducted as participation was anonymous. Inclusion bias may also have affected 
the results, as patients were recruited from several different out-patient clinics, possibly by 
decreasing the numbers of participants with difficulties in completing questionnaires. 
However, as participation in research is optional, this is difficult to overcome. There is a risk 
that patients already diagnosed with ASD will more readily endorse autistic symptoms than 
yet undiagnosed patients who have not already identified themselves with the symptom 
descriptions. A clinical study examining final outcomes after ASD assessment and RAADS-
14 Screen scores would provide a more accurate picture of the screening ability of the 
questionnaire.    
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6 CONCLUSIONS AND CLINICAL IMPLICATIONS 
 
6.1 STUDIES I AND II 
While the core aspects of ASD may be explained by an extreme male cognition pattern of 
high systemizing and low empathizing abilities, our studies show signs of a more 
androgynous physique in ASD, more ambiguous gender identity and gender typical behavior, 
a weaker sexual interest and a less specific heterosexual orientation encompassing both sexes. 
This indicates that at least a sub-category of ASD can be characterized as gender defiant. 
Individuals with ASD often feel different and socially alienated from TD people. A broader 
understanding of common issues in ASD may be helpful in limiting their feelings of 
alienation and improve communication within support services and clinical settings. 
Awareness of the elevated rates of non-normative gender identity and sexuality among 
persons with ASD may give rise to efforts to attenuate the increased stress that adolescence 
poses on ASD.  
 
6.2 STUDY III 
Having a dizygotic twin brother is not associated with more autistic or ADHD traits. Instead, 
parents rate daughters with a twin sister as having slightly more ADHD and autistic traits 
than daughters with a twin brother. This study does not support the hypothesis that elevated 
prenatal testosterone levels result in increased frequency of autistic traits in dizygotic twins. 
 
6.3 STUDY IV 
Our study indicates that the RAADS-14 Screen has good psychometric properties and that 
both men and women diagnosed with ASD endorse significantly more items and more 
persevering symptoms than those with other psychiatric diagnoses, allowing for meaningful 
screening for ASD in psychiatric populations. 
Self-assessment questionnaires do not provide enough information for diagnosing ASD. 
However, when time and resources are limited, the RAADS-14 Screen is a useful instrument 
to assess whether primary care patients and psychiatric out-patients need a referral for a full 
ASD assessment.  
 
6.4 GENERAL CONCLUSIONS AND FUTURE DIRECTIONS 
The data presented in this thesis suggest that sex differences in ASD do not follow clear 
patterns of masculinization. In addition to the core male cognitive style, we have observed 
increased androgyny in physical features and non-male typical patterns of gender roles, 
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sexual behavior, and reactivity to sensory input in individuals with ASD. This sex/gender 
defiant pattern, together with the lack of increased autistic traits in females prenatally exposed 
to testosterone from a twin brother, suggests a relationship between fetal masculinization and 
autistic traits that is, at least in subgroups of ASD, more complex than a straightforward 
relationship between fetal exposure to androgens and autistic traits. The recent findings of a 
dysregulated hormonal RORA feedback loop,
97
 may provide a model for variability in 
androgen and estrogen sensitivity over areas and cell types. 
ASD research is complicated by the heterogeneity of the disorder. Interrelated uncertainties 
regarding sex/gender differences in ASD range from possible flaws, both in the clinical 
definition and recognition of ASD, to the etiological heterogeneity.
85
 Sex differences in 
etiology as well as presentation may result in misleading results when samples are small and 
no sex stratification is conducted. The broad range of sex differences in ASD indicated in this 
thesis underscores the necessity of including a sex/gender perspective in ASD studies. 
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7 SVENSK SAMMANFATTNING 
Den neuropsykiatriska diagnosen autismspektrumtillstånd (AST) innefattar 
funktionsnedsättning och atypiskt beteende avseende social interaktion, kommunikation och 
stereotypa och repetitiva beteenden. AST beror till stor del på genetiska faktorer men även 
miljöfaktorer under fosterutvecklingen antas spela in. Hur dessa riskfaktorer samverkar är 
inte helt klarlagt men utmärkande för AST är att diagnosen är mer än fyra gånger vanligare 
hos män än hos kvinnor. Genom att beskriva och förstå hur könsskillnader är kopplade till 
AST kan vi få ökad förståelse för tillståndets ursprung och en individs risk att utveckla AST. 
Det är också av klinisk betydelse att förstå hur riskfaktorer som drabbar könen olika också 
kan påverka hur symptombilden kan skilja sig mellan kön och individer. 
I den här avhandlingen har jag studerat AST ur ett könsperspektiv utgående från The extreme 
male brain theory of autism (EMB). EMB fastslår att autismens kärnsymptom kan förklaras 
av en hjärna som utvecklats med extremmanliga kognitiva drag vilket innebär en stark 
benägenhet till systematisering av omvärlden och en svagare förmåga till empati. Teorins 
hypotes är att förhöjda testosteronnivåer i fostrets hjärna påverkar dess utveckling, vilket 
resulterar i att individen får mer autistiska drag.  
I studie I och II undersöktes fysiska och psykiska drag som kan tänkas ha påverkats av en 
maskulinisering till följd av förhöjda testosteronnivåer under fostertiden. Vi undersökte 50 
män och kvinnor med AST och 53 köns- och åldersmatchade kontrollpersoner utan AST 
avseende könstypiskt utseende i kropp och ansikte, röstkvalitet, kroppsmått, 
könshormonnivåer, könsidentitet, sexualitet och sexuell preferens. Våra resultat indikerar att 
det inte föreligger någon generell maskulinisering hos vuxna med AST, utan att androgynt 
utseende är vanligare hos både män och kvinnor med AST än hos kontrollgruppen. Gruppen 
med AST uttryckte också en svagare könsidentitet och visade mindre skillnader i 
gendertypiskt beteende än kontrollerna.  
I studie III undersöktes, med hjälp av registerdata, om flickor med en tvåäggstvilling som är 
pojke (och därmed utsatt för förhöjda halter testosteron under fostertiden) har fler autistiska 
eller ADHD-drag än flickor som har en flicktvilling. Överraskande nog visade våra data det 
motsatta resultatet – att flickor med en pojktvilling skattas med något lägre poäng för både 
AST och ADHD.  
I studie IV har vi utvecklat och testat ett självevalueringsformulär för att screena för autism. 
Vi utgick från ett frågeformulär med 80 frågor, RAADS-R. Eftersom många psykiatriska 
symptom överlappar med symptom vid AST är det viktigt att skattningsinstrument testas på 
psykiatriska patienter, vilket gjordes i denna studie. De 14 frågor som bäst kunde särskilja 
AST från andra psykiatriska tillstånd resulterade i formuläret RAADS-14 Screen. Vår studie 
visar att formuläret har god potential som screeningformulär för AST i primärvård och 
psykiatrisk öppenvård och kan indikera om behov av en autismutredning föreligger.  
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RAADS-14-Screen 
 
 
Please choose one of the following alternatives: 
This is true or describes me now and when I was young. 
This was true or describes me only now (refers to skills acquired). 
This was true only when I was young (16 years or younger). 
This was never true and never described me. 
Please answer the questions according to what is true for you.  
Check only one column per statement! 
I.  
Some life experiences and personality 
characteristics that may apply to you 
 
True now 
and when I 
was young 
True 
only 
now 
True only when 
I was younger 
than 16 
Never 
true 
1. It is difficult for me to understand how 
other people are feeling when we are 
talking. 
   
2. Some ordinary textures that do not bother 
others feel very offensive when they touch 
my skin. 
   
3. It is very difficult for me to work and 
function in groups.    
4. It is difficult to figure out what other 
people expect of me.    
5. I often don’t know how to act in social 
situations.    
6. I can chat and make small talk with 
people.    
7. When I feel overwhelmed by my senses, I 
have to isolate myself to shut them down.    
8. How to make friends and socialize is a 
mystery to me.    
9. When talking to someone, I have a hard 
time telling when it is my turn to talk or to 
listen. 
   
10. Sometimes I have to cover my ears to 
block out painful noises (like vacuum 
cleaners or people talking too much or too 
loudly). 
   
11. It can be very hard to read someone’s 
face, hand, and body movements when 
we are talking. 
   
12. I focus on details rather than the overall 
idea.    
13. I take things too literally, so I often miss 
what people are trying to say.    
14. I get extremely upset when the way I like 
to do things is suddenly changed    
 
